Does the injection site (stomach, thigh, arm) affect how long GLP-1 stays in my system
Ezras role in proactive health At Ezra, we believe that taking a science-first approach is the most reliable path to lasting health outcomes
Weight Loss & Metabolic Research GLP-1 agonists including Semaglutide, Retatrutide, Tirzepatide, Tesamorelin, AOD-9604, and Tesofensine for fat loss and metabolic pathway studies
Glucagon-like peptide-1 receptor agonists compared with basal insulins for the treatment of type 2 diabetes mellitus: a systematic review and meta-analysis
NICE guidelines (NG28) recommend specific injectable GLP-1 receptor agonists for type 2 diabetes management in appropriate clinical contexts
Retatrutide activates more receptors but also recruits more of the off-switch